Skip to content

The Study of Molecular Mechanism on Cerebral Arteriovenous Malformations

The Study of Molecular Mechanism on Cerebral Arteriovenous Malformations

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-CIC-15007511
Enrollment
Unknown
Registered
2015-11-13
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral arteriovenous malformation

Interventions

Sponsors

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with cerebral vascular malformation confirmed by iconography; 2. Aged 6 to 70 years; 3. Patients or their families were informed and signed informed consent.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
gene expression level;

Countries

China

Contacts

Public ContactZhili Li
xiaolifeidao_med@sina.com+86 13808067618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026